Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: May 13, 2025
Q1 2025 Net Product Sales Increased 77% Year-over-Year to $3.1 Million
Sustained Momentum Driven by Growing Prescriber Adoption and Repeat Patient Use
Read more at globenewswire.com5.53
-0.81 (-12.78%)
Find more stocks in the Stock Screener
EVOK Latest News and Analysis
